Stakes Get Bigger as Patient Health and Success of Humanigen Platform Depend on Evidence from COVID-19 Clinical Trials

San Francisco Bay Area biotech venture Humanigen, Inc. (HGEN), formerly known as KaloBios Pharmaceuticals, is a clinical stage company focused on preventing and treating cytokine storm with lenzilumab, their proprietary Humaneered® anti-human granulocyte...

Pin It on Pinterest